- Home
- NPV vs BIOA Comparison
NPV vs BIOA Comparison
Compare NPV & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPV
- BIOA
- Stock Information
- Founded
- NPV 1993
- BIOA 2015
- Country
- NPV United States
- BIOA United States
- Employees
- NPV N/A
- BIOA N/A
- Industry
- NPV Investment Managers
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- NPV Finance
- BIOA Health Care
- Exchange
- NPV Nasdaq
- BIOA Nasdaq
- Market Cap
- NPV 211.4M
- BIOA 175.7M
- IPO Year
- NPV N/A
- BIOA 2024
- Fundamental
- Price
- NPV N/A
- BIOA $5.60
- Analyst Decision
- NPV
- BIOA Hold
- Analyst Count
- NPV 0
- BIOA 4
- Target Price
- NPV N/A
- BIOA $5.67
- AVG Volume (30 Days)
- NPV 38.9K
- BIOA 190.6K
- Earning Date
- NPV 01-01-0001
- BIOA 11-06-2025
- Dividend Yield
- NPV 3.90%
- BIOA N/A
- EPS Growth
- NPV N/A
- BIOA N/A
- EPS
- NPV N/A
- BIOA N/A
- Revenue
- NPV N/A
- BIOA $3,863,000.00
- Revenue This Year
- NPV N/A
- BIOA N/A
- Revenue Next Year
- NPV N/A
- BIOA N/A
- P/E Ratio
- NPV N/A
- BIOA N/A
- Revenue Growth
- NPV N/A
- BIOA N/A
- 52 Week Low
- NPV $8.92
- BIOA $2.88
- 52 Week High
- NPV $11.55
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- NPV 50.20
- BIOA 60.70
- Support Level
- NPV $11.42
- BIOA $5.55
- Resistance Level
- NPV $11.63
- BIOA $6.00
- Average True Range (ATR)
- NPV 0.08
- BIOA 0.28
- MACD
- NPV -0.03
- BIOA 0.01
- Stochastic Oscillator
- NPV 14.12
- BIOA 63.47
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.